Sensei Biotherapeutics, Inc. (SNSE)
23.64
-0.12
(-0.51%)
USD |
NASDAQ |
May 08, 10:44
Sensei Biotherapeutics Research and Development Expense (Annual) : 10.96M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Oncolytics Biotech, Inc. | 13.31M |
| Vir Biotechnology, Inc. | 432.80M |
| Acurx Pharmaceuticals, Inc. | 1.834M |
| Tango Therapeutics, Inc. | 129.88M |
| Xilio Therapeutics, Inc. | 56.04M |